Hann-Chorng Kuo Selected Research

Brain-Derived Neurotrophic Factor (BDNF)

1/2023	EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis/bladder pain syndrome with Hunner's lesion.
10/2022	Potential urine biomarkers in bladder outlet obstruction-related detrusor underactivity.
4/2022	Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
1/2014	Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hann-Chorng Kuo Research Topics

Disease

77	Overactive Urinary Bladder (Overactive Bladder) 04/2024 - 06/2008
76	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/2024 - 01/2003
40	Inflammation (Inflammations) 02/2024 - 03/2011
40	Pain (Aches) 02/2024 - 01/2005
32	Lower Urinary Tract Symptoms 04/2024 - 01/2002
27	Urinary Tract Infections (Urinary Tract Infection) 04/2024 - 07/2005
24	Urinary Incontinence 03/2024 - 11/2008
20	Stress Urinary Incontinence 04/2024 - 01/2005
17	Underactive Urinary Bladder 04/2023 - 03/2003
16	Urinary Retention 03/2024 - 03/2003
16	Cystitis 07/2023 - 09/2010
15	Spinal Cord Injuries (Spinal Cord Injury) 11/2023 - 06/2009
15	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 01/2009
13	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2023 - 05/2004
10	Nocturia 01/2023 - 11/2012
9	Ataxia (Dyssynergia) 03/2024 - 01/2008
7	Dysuria 01/2023 - 03/2003
7	Urge Urinary Incontinence (Urge Incontinence) 01/2022 - 01/2007
6	Stroke (Strokes) 03/2024 - 01/2004
6	Urologic Diseases (Urinary Tract Disease) 12/2023 - 09/2010
6	Hypersensitivity (Allergy) 12/2022 - 01/2013
5	Pelvic Pain 01/2024 - 06/2015
5	Infections 01/2023 - 12/2011
5	Hyperplasia 01/2023 - 04/2011
5	Ulcer 05/2022 - 03/2013
4	Dementia (Dementias) 03/2024 - 01/2014
4	Urinary Bladder Diseases (Bladder Diseases) 03/2023 - 06/2015
4	Autonomic Dysreflexia 01/2023 - 07/2015
4	Shock 01/2023 - 01/2021
4	Neoplasms (Cancer) 01/2022 - 09/2008
3	Parkinson Disease (Parkinson's Disease) 03/2024 - 01/2014
3	Hydronephrosis 07/2023 - 11/2014
3	Fibrosis (Cirrhosis) 07/2023 - 11/2019
3	Hematuria 01/2023 - 07/2005
3	Constipation 10/2022 - 01/2021
3	Diabetes Mellitus 01/2020 - 11/2014
3	Paralysis (Palsy) 01/2020 - 09/2015
3	Chronic Kidney Failure (Chronic Renal Failure) 04/2019 - 04/2012
3	Prostatitis 01/2019 - 06/2015
3	Disease Progression 09/2015 - 10/2009
2	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 07/2023 - 10/2007
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 09/2008
2	Cognitive Dysfunction 01/2022 - 01/2016
2	Multiple Sclerosis 12/2020 - 09/2015
2	Sensation Disorders 01/2020 - 01/2013
2	Neurogenic Inflammation 01/2019 - 09/2015

Drug/Important Bio-Agent (IBA)

80	Type A Botulinum Toxins (Botox)FDA Link 03/2024 - 03/2003
50	incobotulinumtoxinA FDA Link 03/2024 - 01/2008
30	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2008
29	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2008
27	Nerve Growth Factor (NGF)IBA 10/2022 - 09/2007
22	Therapeutic UsesIBA 09/2023 - 02/2006
20	Muscarinic AntagonistsIBA 03/2024 - 06/2009
15	Ketamine FDA LinkGeneric 07/2023 - 12/2013
14	mirabegronIBA 03/2024 - 09/2015
12	CytokinesIBA 02/2024 - 01/2013
8	Botulinum Toxins (Botulinum Toxin)IBA 01/2024 - 04/2014
8	Cadherins (E-Cadherin)IBA 01/2022 - 07/2011
6	Liposomes (Liposome)IBA 01/2023 - 06/2014
5	Solifenacin Succinate FDA Link 10/2023 - 03/2014
5	C-Reactive ProteinIBA 01/2014 - 03/2011
4	ChemokinesIBA 04/2024 - 01/2013
4	Interleukin-8 (Interleukin 8)IBA 04/2024 - 01/2013
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023 - 01/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2013
4	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 09/2015
4	Tryptases (Tryptase)IBA 04/2021 - 05/2015
4	Polypropylenes (Polypropylene)IBA 03/2017 - 01/2005
3	8-epi-prostaglandin F2alphaIBA 04/2024 - 07/2022
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 01/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023 - 04/2017
3	Dinoprostone (PGE2)FDA Link 04/2022 - 12/2010
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 09/2015
3	Tamsulosin (Flomax)FDA LinkGeneric 04/2019 - 02/2009
3	Hormones (Hormone)IBA 01/2019 - 09/2008
3	Prostate-Specific Antigen (Semenogelase)IBA 11/2018 - 09/2008
3	Immunoglobulin E (IgE)IBA 01/2016 - 10/2014
3	Tolterodine Tartrate (Detrol)FDA Link 09/2015 - 02/2009
2	Nerve Growth Factors (Neurotrophins)IBA 10/2022 - 11/2019
2	Chemokine CCL5IBA 04/2022 - 01/2020
2	Chemokine CCL11IBA 04/2022 - 01/2020
2	Parasympatholytics (Antispasmodics)IBA 01/2022 - 06/2009
2	Cholinergic Antagonists (Anticholinergics)IBA 10/2021 - 05/2005
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 04/2021 - 01/2021
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021 - 06/2015
2	Purinergic P2X3 ReceptorsIBA 04/2019 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2019 - 12/2013
2	Tight Junction ProteinsIBA 11/2016 - 04/2014

Therapy/Procedure

48	Injections 03/2024 - 09/2007
29	Therapeutics 11/2023 - 01/2009
26	Aftercare (After-Treatment) 03/2024 - 05/2004
24	Intravesical Administration 11/2023 - 01/2007
11	Suburethral Slings (Tension-Free Vaginal Tape) 04/2024 - 01/2007
4	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 01/2002
3	Operative Surgical Procedures 04/2024 - 01/2022
3	Transurethral Resection of Prostate (TURP) 01/2019 - 01/2002
2	Anesthesia 01/2023 - 01/2013
2	Denervation 10/2022 - 01/2002
2	Microspheres (Microsphere) 04/2022 - 03/2012
2	Replantation 01/2017 - 11/2014